Balancing the cost and value of medications: the dilemma facing clinicians.
about
Preferred drug lists: potential impact on healthcare economics.The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study.Medication Use by Race and Ethnicity in Women Transitioning Through the Menopause: A Study of Women's Health Across the Nation Drug Epidemiology Study.The pharmacoeconomics of acne treatment: where are we heading?
P2860
Balancing the cost and value of medications: the dilemma facing clinicians.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Balancing the cost and value of medications: the dilemma facing clinicians.
@ast
Balancing the cost and value of medications: the dilemma facing clinicians.
@en
type
label
Balancing the cost and value of medications: the dilemma facing clinicians.
@ast
Balancing the cost and value of medications: the dilemma facing clinicians.
@en
prefLabel
Balancing the cost and value of medications: the dilemma facing clinicians.
@ast
Balancing the cost and value of medications: the dilemma facing clinicians.
@en
P1433
P1476
Balancing the cost and value of medications: the dilemma facing clinicians.
@en
P2093
Jerry Avorn
P356
10.2165/00019053-200220003-00006
P478
20 Suppl 3
P577
2002-01-01T00:00:00Z
P6179
1009512204